Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator-Initiated, Randomized, Double-Blind, Double-Dummy Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram.

NCT07645807 is registered in ClinicalTrials.gov with Sichuan Credit Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07645807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07645807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator-Initiated, Randomized, Double-Blind, Double-Dummy Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram.
Lead sponsor
Sichuan Credit Pharmaceutical Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 11, 2026
Completion date
January 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjunct in the treatment of depressive disorder